Patents by Inventor Ellen CAHIR-MCFARLAND

Ellen CAHIR-MCFARLAND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230390270
    Abstract: Disclosed is a method of treating a human subject with multiple sclerosis. The method comprises administering to the subject in the absence of a cholesterol lowering drug an effective amount of Compound 1: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 19, 2021
    Publication date: December 7, 2023
    Inventors: Shibeshih Belachew, Ellen Cahir-McFarland, Zhaohui Shao, Hui-Hsin Tsai, Ru Wei
  • Publication number: 20230310405
    Abstract: Disclosed is a method of lowering elevated cholesterol plasma levels in a subject. Also disclosed is a method of treating hypercholesterolemia in a subject. The methods comprise administering to the subject in the absence of a cholesterol lowering drug an effective amount of Compound 1 or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 19, 2021
    Publication date: October 5, 2023
    Inventors: Shibeshih Belachew, Ellen Cahir-McFarland, Zhaohui Shao, Hui-Hsin Tsai, Ru Wei
  • Publication number: 20200197544
    Abstract: Provided herein, in some aspects, are methods of administering to a subject a thymidine kinase substrate having a label and detecting presence or absence of the label as an indication of the presence of a polyomavirus (e.g., JCV and BK).
    Type: Application
    Filed: April 26, 2017
    Publication date: June 25, 2020
    Inventors: Ellen CAHIR-MCFARLAND, Daniel BRADLEY, Maciej KALISZCZAK